MiNK Therapeutics, Inc. INKT
NASDAQ · United States · Health Technology
$12.44-0.29 (-2.28%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-13 | -0.62 | -0.60 | -3.3% | $0 | — | -0.8%$11.36→$11.27 |
| Q1 2026 | 2026-05-15 | -0.57 | -0.77 | +26.0% | — | — | -4.5%$10.51→$10.04 |
| Q4 2025 | 2026-03-31 | -0.56 | -0.68 | +17.6% | — | — | +0.5%$10.52→$10.57 |
| Q3 2025 | 2025-11-14 | -0.65 | -0.85 | +23.5% | — | — | -9.2%$13.22→$12.00 |
| Q1 2025 | 2025-05-15 | -0.70 | -0.61 | -14.8% | — | — | — |
| Q4 2024 | 2025-03-18 | -0.62 | -0.50 | -24.0% | — | — | — |
| Q2 2024 | 2024-08-13 | -0.70 | -0.97 | +27.8% | — | — | — |
| Q1 2024 | 2024-05-14 | -1.10 | -1.53 | +28.1% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.